# Patient Reported Outcome Measures (PROMs) With Trabectedin

> **NCT03959033** · — · TERMINATED · sponsor: **University of Leeds** · enrollment: 7 (actual)

## Conditions studied

- Sarcoma
- Liposarcoma
- Leiomyosarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03959033
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-29
- **Primary completion:** 2019-08-28
- **Final completion:** 2019-08-28
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Insufficient accrual
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959033, "Patient Reported Outcome Measures (PROMs) With Trabectedin". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03959033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*